Colfosceril palmitate is a synthetic phospholipid serving as a lung surfactant replacement, primarily indicated for the treatment of respiratory distress syndrome in premature infants. By reducing alveolar… Read more
Colfosceril palmitate is a synthetic phospholipid serving as a lung surfactant replacement, primarily indicated for the treatment of respiratory distress syndrome in premature infants. By reducing alveolar surface tension and stabilizing lung function, this critical therapeutic agent requires rigorous quality control and monitoring during pharmaceutical development. This category includes essential reference standards for colfosceril palmitate, along with its identified impurities and stable isotope-labelled compounds, such as deuterated derivatives. These analytical tools are vital for laboratories engaged in impurity profiling, bioanalytical assay development, and robust method validation. By utilizing these precise reference materials, researchers can ensure accurate quantification and maintain strict regulatory compliance throughout their pharmaceutical testing and quality assurance programs, ultimately supporting the consistency and efficacy of surfactant formulations within the manufacturing lifecycle.